Cargando…

Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis

IMPORTANCE: The proportion of macrolide-resistant Mycoplasma pneumoniae (MRMP) infections has changed, and it differs according to geographical region. OBJECTIVE: To analyze the global patterns, including the temporal trends, regional variations, and variant types, in the proportion of MRMP infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kyunghoon, Jung, Sungsu, Kim, Mina, Park, Suyeon, Yang, Hyeon-Jong, Lee, Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274321/ https://www.ncbi.nlm.nih.gov/pubmed/35816304 http://dx.doi.org/10.1001/jamanetworkopen.2022.20949

Ejemplares similares

Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong, et al.
Publicado: (2017)

Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong
Publicado: (2019)

Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
por: Choi, Yun Jung, et al.
Publicado: (2022)

Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
por: Ahn, Jong Gyun, et al.
Publicado: (2021)

Recent Trends in the Epidemiology, Diagnosis, and Treatment of Macrolide-Resistant Mycoplasma pneumoniae
por: Oishi, Tomohiro, et al.
Publicado: (2022)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
por: Lee, Hyunju, et al.
Publicado: (2021)

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)

Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
por: Hong, Ki Bae, et al.
Publicado: (2013)

Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials
por: Kim, Hwan Soo, et al.
Publicado: (2019)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
por: Averbuch, Diana, et al.
Publicado: (2011)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
por: Wu, Han-Meng, et al.
Publicado: (2012)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia
por: Yoon, In Ae, et al.
Publicado: (2017)

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
por: Tanaka, Takaaki, et al.
Publicado: (2017)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014)

Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics
por: Liu, Xijie, et al.
Publicado: (2014)

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment
por: Pereyre, Sabine, et al.
Publicado: (2016)

Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju
por: Kim, Yoon-Joo, et al.
Publicado: (2017)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia
por: Zhou, Yajuan, et al.
Publicado: (2020)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Ha, Seok Gyun, et al.
Publicado: (2018)

Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea
por: Lee, Joon Kee, et al.
Publicado: (2018)

Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis
por: Lee, Eun, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
por: Lanata, Mariana M., et al.
Publicado: (2021)

Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
por: Komatsu, Haruki, et al.
Publicado: (2014)

Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting
por: Wang, Yacui, et al.
Publicado: (2021)

Characteristics of the Mycoplasma pneumoniae Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends
por: Shin, Soyoun, et al.
Publicado: (2023)

Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae
por: Narita, Mitsuo
Publicado: (2011)

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
por: Eshaghi, AliReza, et al.
Publicado: (2013)

Mycoplasma pneumoniae Macrolide Resistance in Children in Central Ohio Detected by Sequencing
por: Lanata Piazzon, Mariana, et al.
Publicado: (2017)

Clinical features and seasonal variations in the prevalence of macrolide‐resistant Mycoplasma pneumoniae
por: Akashi, Yusaku, et al.
Publicado: (2018)

The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children
por: Leng, Maodong, et al.
Publicado: (2023)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
por: Ishiguro, Nobuhisa, et al.
Publicado: (2017)

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Xie, Qiaoyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vf8gvnuqbph4t4v8pg7180cnt